Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea
Public ClinicalTrials.gov record NCT01355471. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized Double-Blind, Vehicle-Controlled, Parallel Group Study to Demonstrate the Efficacy and Safety of CD07805/47 Gel Applied Topically Once Daily in Subjects With Moderate to Severe Facial Erythema Associated With Rosacea
Study identification
- NCT ID
- NCT01355471
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Galderma R&D
- Industry
- Enrollment
- 293 participants
Conditions and interventions
Conditions
Interventions
- CD07805/47 Gel Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2011
- Primary completion
- Oct 31, 2011
- Completion
- Dec 31, 2011
- Last update posted
- Feb 17, 2021
2011 – 2012
United States locations
- U.S. sites
- 12
- U.S. states
- 12
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Burke Pharmaceutical Research | Hot Springs | Arkansas | 71913 | — |
| Baumann Cosmetic and Research Institute | Miami Beach | Florida | 33140 | — |
| MedaPhase, Inc. | Newnan | Georgia | 30263 | — |
| Dermatology Specialists Research | Louisville | Kentucky | 40202 | — |
| Grekin Skin Institute | Warren | Michigan | 48088 | — |
| Central Dermatology PC | St Louis | Missouri | 63117 | — |
| Skin Specialty Dermatology | New York | New York | 10155 | — |
| Haber Dermatology & Cosmetic Surgery | South Euclid | Ohio | 44118 | — |
| Oregon Dermatology and Research Center | Portland | Oregon | 97210 | — |
| Palmetto Clinical Trial Services, LLC | Greenville | South Carolina | 29607 | — |
| J&S Studies Inc. | College Station | Texas | 77845 | — |
| Premier Clinical Research | Spokane | Washington | 99201 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01355471, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 17, 2021 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01355471 live on ClinicalTrials.gov.